The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of a prognostic 53-immune-gene panel in stage II/III melanoma.
 
Margaret Borgardus
No Relationships to Disclose
 
Robyn Denise Gartrell
Consulting or Advisory Role - Takeda
Patents, Royalties, Other Intellectual Property - Amgen; Columbia University (Inst)
Travel, Accommodations, Expenses - Perkin Elmer
 
Douglas Kanter Marks
No Relationships to Disclose
 
Camden L Esancy
No Relationships to Disclose
 
Sarabjot Pabla
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Patents, Royalties, Other Intellectual Property - OmniSeq
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb; Celyad; EMD Serono; Lion Biotechnologies; Omniseq
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merrimack (Inst)
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Immunocore; Merck; Novartis; Roche
Research Funding - Merck (Inst); Prometheus (Inst)
 
Rui R. Chang
No Relationships to Disclose
 
Bret Taback
Speakers' Bureau - Prometheus
 
Sandra J. Lee
Employment - NantWorks (I)
Stock and Other Ownership Interests - NantWorks (I)
Consulting or Advisory Role - Roche/Genentech
 
John Krolewski
No Relationships to Disclose
 
Carl Morrison
Employment - OmniSeq
Leadership - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Consulting or Advisory Role - NanoString Technologies
Patents, Royalties, Other Intellectual Property - OmniSeq (Inst)
 
Yvonne M. Saenger
Research Funding - Amgen; Intensity Therapeutics
Patents, Royalties, Other Intellectual Property - Amgen; OmniSeq
Travel, Accommodations, Expenses - Rockpointe